Her point: semaglutide drugs like Wegovy and Ozempic need a legal prescriber, and a dietitian handing them out without that authority is a red flag.
Recap by typeshit. Post by @nutritionist.mishal on Instagram.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
CBS19 reports on research suggesting app-based support and structured meal plans may help people hold their weight after coming off GLP-1 drugs.
Both companies shared aging clock data at a research conference, including Novo blood samples from 10,052 people. Geneticist Steve Horvath called the effect strong.
Loading…